Print
Email
Print Edition StoriesWednesday, December 16, 2009
Biocius Life Sciences spinout complete
By Mass High Tech staff
Funding drugs for rare diseases
MHT's Julie Donnelly: Life science startups finding investments
MHT's Marc Songini: Technology to keep seniors healthy
Biocius Life Sciences is now operating as an independent company, following its formation in November by Woburn biotech BioTrove Inc. and its subsequent spin-out.
Biocius, also based in Woburn, was created to hold BioTrove’s RapidFire intellectual property separately from Carlsbad, Calif.-based Life Technologies Corp. (Nasdaq: LIFE), which is acquiring BioTrove. As a result of the spinout, all BioTrove RapidFire business unit employees now work for Biocius.
Biocius, which is being led by chairman and CEO Jeffrey Leathe, the former chief financial officer of BioTrove, lists its backers as Catalyst Health Ventures, Excel Venture Management, Fletcher-Spaght, CB Health Ventures, Vox Equity Partners, Echelon Ventures and BioFrontier Partners.
The RapidFire mass spectrometry platform is designed to enable the acceleration of drug discovery and pipeline decisions.
Biocius derives its names from the Greek word for “life” (“Bio”) and the Latin word for “faster” (“ocious”).
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
